| Evaluation of D-Fi for the Treatment of Wounds Due to DEB (NCT06892639) | Castle Creek Biosciences, LLC. | 2025-03-27 |
| A Study of FCX-007 for Recessive Dystrophic Epidermolysis Bullosa (NCT04213261) | Castle Creek Biosciences, LLC. | 2020-06-09 |
| A Study of FCX-013 Plus Veledimex for the Treatment of Moderate to Severe Localized Scleroderma (Morphea) (NCT03740724) | Castle Creek Biosciences, LLC. | 2019-12-18 |
| A Study of FCX-007 for Recessive Dystrophic Epidermolysis Bullosa (RDEB) (NCT02810951) | Castle Creek Biosciences, LLC. | 2016-07-01 |
| Controlled Study to Evaluate the Safety and Efficacy of Azficel-T for Vocal Fold Scarring and Age-Related Dysphonia (NCT02120781) | Castle Creek Biosciences, LLC. | 2014-03-01 |
| Pilot Study of Azficel-T for the Treatment of Restrictive Burn Scars (NCT01858753) | Castle Creek Biosciences, LLC. | 2013-05-01 |
| Pilot Safety and Efficacy Study of Isolagen Therapy in Treatment of Restrictive Burn Scars (NCT00620737) | Castle Creek Biosciences, LLC. | 2008-02-01 |
| Safety and Efficacy Study of Autologous Fibroblasts in the Treatment of Severe Facial Acne Scarring (NCT00642642) | Castle Creek Biosciences, LLC. | 2007-11-01 |
| Safety and Efficacy Study of Isolagen TherapyTM in Treatment of Facial Wrinkles and Creases (NCT00654654) | Castle Creek Biosciences, LLC. | 2007-03-01 |
| Safety and Efficacy Study of Isolagen Therapy in the Treatment of Nasolabial Fold Wrinkles (NCT00655356) | Castle Creek Biosciences, LLC. | 2006-11-01 |
| Safety and Efficacy Study of Isolagen TherapyTM in the Treatment of Nasolabial Fold Wrinkles (NCT00649428) | Castle Creek Biosciences, LLC. | 2006-10-01 |
| Safety and Efficacy Study of Isolagen TherapyTM in Treatment of Interdental Papillary Insufficiency (NCT00655889) | Castle Creek Biosciences, LLC. | 2006-01-01 |